Results 201 to 210 of about 19,474 (223)

Composition-tunable polycarboxylic acid-stabilized ultrasmall amorphous paramagnetic nanoclusters as multifunctional MRI contrast agents. [PDF]

Mater Today Bio
Xiao S, Sun T, Zhang L, Yang Y, Yang X, Liu X, Zhao Y, Zhang Z, Zhang W, Zhou C, Gong M, Zhang D.   +11 more
europepmc   +1 more source

GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma.

New England Journal of Medicine, 2023
BACKGROUND Immunotherapy with chimeric antigen receptor (CAR)-expressing T cells that target the disialoganglioside GD2 expressed on tumor cells may be a therapeutic option for patients with high-risk neuroblastoma.
F. del Bufalo, B. De Angelis, I. Caruana, G. Del Baldo, M. D. De Ioris, A. Serra, A. Mastronuzzi, M. Cefalo, D. Pagliara, M. Amicucci, Giuseppina Li Pira, Giovanna Leone, V. Bertaina, M. Sinibaldi, S. Di Cecca, M. Guercio, Z. Abbaszadeh, L. Iaffaldano, M. Gunetti, S. Iacovelli, Rossana Bugianesi, S. Macchia, M. Algeri, P. Merli, F. Galaverna, Rachid Abbas, M. Garganese, M. F. Villani, G. Colafati, F. Bonetti, M. Rabusin, K. Perruccio, Veronica Folsi, C. Quintarelli, F. Locatelli   +34 more
semanticscholar   +3 more sources

GD2 Expression in Medulloblastoma and Neuroblastoma for Personalized Immunotherapy: A Matter of Subtype

Cancers, 2022
Neuroblastoma (NBL) and medulloblastoma (MB) are aggressive pediatric cancers which can benefit from therapies targeting gangliosides. Therefore, we compared the ganglioside profile of 9 MB and 14 NBL samples by thin layer chromatography and mass ...
Sara Ersali, Katrin Frauenknecht, Jörg Faber   +2 more
exaly   +2 more sources

Variable Expression of the Disialoganglioside GD2 in Breast Cancer Molecular Subtypes [PDF]

Cancers, 2021
The disialoganglioside GD2 is a tumor-associated antigen that may allow for the application of targeted immunotherapies (anti-GD2 antibodies, GD2 CAR T cells) in patients with neuroblastoma and other solid tumors.
Hanna Huebner, Sareetha Kailayangiri, Andreas Mackensen   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results

Nature Medicine, 2023
A. Heczey, Xin Xu, Amy N. Courtney, Geng-Wen Tian, Gabriel A. Barragán, Lin-Jie Guo, C. M. Amador, Nisha Ghatwai, Purva Rathi, Michael S. Wood, Yan-Chuan Li, Chun-Chao Zhang, T. Demberg, Erica J. Di Pierro, A. Sher, Hui-Min Zhang, B. Mehta, Sachin G. Thakkar, B. Grilley, Tao Wang, Brian D. Weiss, A. Montalbano, M. Subramaniam, Chen-Ling A. Xu, Chirag Sachar, Daniel K. Wells, G. Dotti, L. Metelitsa   +27 more
semanticscholar   +1 more source

Chemoenzymatic Synthesis of 9NHAc-GD2 Antigen to Overcome the Hydrolytic Instability of O-Acetylated-GD2 for Anticancer Conjugate Vaccine Development

Angewandte Chemie - International Edition, 2021
Paulo Vilar Saavedra, Jeffrey C Gildersleeve, Tayeb Kakeshpour   +2 more
exaly  

GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/2 trial

Nature Medicine
F. Locatelli, D. Pagliara, M. D. De Ioris, M. Becilli, G. Del Baldo, A. Serra, A. Mastronuzzi, M. Cefalo, Giuseppina Li Pira, Giovanna Leone, V. Bertaina, F. Fabozzi, M. Di Nardo, C. Rosignoli, M. L. D'Andrea, A. Crocoli, S. Vennarini, M. Sinibaldi, S. Di Cecca, M. Guercio, L. Iaffaldano, B. Lucarelli, M. Algeri, P. Merli, G. Colafati, B. De Angelis, C. Quintarelli, F. del Bufalo   +27 more
semanticscholar   +1 more source

Donor-derived GD2-specific CAR T cells in relapsed or refractory neuroblastoma

Nature Medicine
C. Quintarelli, F. del Bufalo, M. D. De Ioris, M. Guercio, M. Algeri, D. Pagliara, D. Silvestris, M. Di Nardo, M. Sinibaldi, S. Di Cecca, L. Iaffaldano, S. Manni, Valentina Fustaino, M. Garganese, G. Colafati, V. Bertaina, M. Becilli, A. Mastronuzzi, F. Fabozzi, Monica Gunetti, S. Iacovelli, Rossana Bugianesi, S. Macchia, Giuseppina Li Pira, M. Cefalo, Giovanna Leone, G. Del Baldo, B. De Angelis, F. Locatelli   +28 more
semanticscholar   +1 more source

Top bar navigation

Frontiers in Oncology, 2020
Bassel Nazha, Taofeek K. Owonikoko
exaly